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     Nosocomial distribution of Serratia marcescens at two university hospitals was studied 
by bacteriocin typing and antibiogram from January 1981 to July 1983, and the results 
were compared. The 126 strains isolated from Medical College Hospital of Oita (MCHO) 
consisted mainly of bacteriocin types 4 (29%), 9 (23%), 52 (19%) and 42 (6%) , and 
the 86 from Nagasaki University Hospital (NUH) were mainly of types 14 (20%) , 4 (17%), 
9 (12%) and 26 (12%); these four types amounted to 77% and 61% respectively. Types 
4 and 9 which formed a high proportion of isolates at both hospitals were apparently the 
most common bacteriocin types. Using 154 strains of the bacteriocin types 4 , 9, 14, 26, 
42 and 52 of S. marcescens, antibiogram with 13 antimicrobial agents was tested. The 
strains isolated from MCHO were found to be more resistant than those from NUH. 
The isolates of S. marcescens at each hospital showed characteristic , different distribution 
in bacteriocin type and antibiogram. The close relation was not always observed between 
antibiograms and bacteriocin types. 
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                  INTRODUCTION 
     Serratia marcescens, a member of the tribe Klebsiellae, has been reported with 
increasing frequency as a cause of nosocomial infection. Urinary tract infection, 
bacteremia, respiratory tract infection and wound infection involving S. marcescens have
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been often encountered in hospitalized patients with severe underlying deseases5)1819 
Most of S. marcescens strains are resistant to 9-lactam compounds, aminoglycosides, 
nalidixic acid and colistin. The mechanism of antimicrobial resistance is mostly due to 
drug inactivating enzymes such as jS-lactamase mediated by R-plasmids2)8). 
     The authors recently obtained the indicator strains for bacteriocin typing of S. 
marcescens from Professor TRAUB, and the typing was carried out according to the meth-
od of TRAUB, RAYMOND and STARTSMAN17) for the isolates from the patients admitted 
to two university hospitals, Medical College Hospital of Oita (MCHO, 600 beds) and 
Nagasaki University Hospital (NUH, 780 beds). This paper presents the results of a 
comparison of bacteriocin types and antibiograms of S. marcescens isolates at two uni-
versity hospitals. 
              MATERIALS AND METHODS 
Bacteria: A total of 212 strains of S. marcescens used in this study consisted of 126 
isolates from MCHO and 86 from NUH. These bacteria were all collected from hospi-
talized patients during the period from January 1981 to July 1983, excluding reisolates 
from the same patient. These organisms were identified and stored at room temperature 
in the dark as previously described") 12) . The sources of S. marcescens from patients are 
shown in Table 1. The indicator strains used for bacteriocin typing were those reported 
by TRAUB, W. H . , et al. 17) .
Bacteriocin typing of S. marcescens : Bacteriocin solutions were prepared by a method 
similar to that of TRAUB, W. H., et al.") and the isolates were typed by bacteriocin 
sensitivity as previously reported"). The bacteriocin types were determined by the bac-
teriocin sensitivity pattern of TRAUB, W. H., et al. 14)15)11) 
Antimicrobial agents : The following 14 compounds used in the current study were 
kindly supplied as follows; ceftazidime (Nihon Glaxo Co.), ceftriaxone (Nihon Roche 
Co.), latamoxe f (Shionogi Co.), azthreonam (Taito-P feizer Co.), imipenem (Merk-Banyu 
Co.), norfloxacin (Kyorin Yakuhin Co.), ciprofloxacin (Bayer Yakuhin Co.), ofloxacin 
(Daiichi Seiyaku Co.), enoxacin (Dainihon Seiyaku Co.), gentamicin (Shionogi Co.), 
amikacin (Merk-Banyu Co.), tobramycin (Shionogi Co.), sisomicin (Bayer Yakuhin Co.) 
and astromicin (Kyowa Hakko Co.). 
Susceptibility testing : The strains used for this study were selected for the most common 
bacteriocin types at the both hospitals, i.e. showing types 4, 9, 14, 26, 42 and 52. 
There were 154 strains composed of 101 isolates from MCHO and 53 from NUH. Sus-
ceptibility tests were made by the agar plate dilution technique. The strains were grown 
at 37°C for 14 hours in Mueller-Hinton broth (BBL) and further diluted in broth to 
provide 105 colony forming unit when delivered to the surface of test media with a mul-
tipoint inoculator (Sakuma Co., Japan). Doubling dilutions of antibiotics were prepared 
in 10 mM phosphate buffer (pH 7.2) to final concentrations of 100^0.05 ,rug/ml in
Mueller-Hinton agar medium (BBL). Following incubation at 37°C for 14 hours the 
minimum inhibitory concentration (MIC) was defined as the lowest concentration resulting 
in the suppression o f the growth. 
                     RESULTS 
Comparison of the bacteriocin types between two hospitals : Table 1 and Fig. 1 show the 
distribution o f S. marcescens bacteriocin types at both MCH O and NUH. The 126 strains 
isolated from MCHO were divided into eight types, mainly 4, 9, 52 and 42; 15 (12%) 
were nontypable. These four types amounted to 77%. The 86 strains isolated from NUH 
were classified into 18 types, mainly 14, 4, 9 and 26 ; 14 (16%) were nontypable. These 
four types amounted to 61%. Bacteriocin type 42 which was one of the major types at 
MCHO was not isolated from NUH ; on the other hand, type 26 which was one of the 
major types at NUH was not isolated from MCHO. S. marcescens types 4, 9 and 52 were 
more frequently isolated from MCHO than from NUH. Type 26 of S. marcescens which was 
not found at MCHO was isolated mainly from urine at NUH, and type 42 which was not 
found at NUH was isolated from sputa at MCHO. 
The distribution of S. marcescens bacteriocin types : The distribution of bacteriocin types
                                 Bacteriocin type* 
Fig. 1. Distribution of Serratia marcescens at Medical College Hospital of Oita (MCHO) 
      andNagasaki University Hospital (NUH) during 1981-1983. 
      * See TRAUB & RAYMOND , 1971; TRAUB, 1972; TRAUB & KLEBER, 1974. 
       ** Unclassifiable . 
       *** Nontypable .
of S. marcescens at NUH has been previously 'reported 12). The distribution at MCHO is, 
therefore, reported in this paper (Table 2). Patients admitted to the wards of Urology, 
Medicine and Surgery were found to be the major hosts of S. marcescens infections, which 
were mostly of types 4, 9 and 52. The main infection sites of S. marcescens were urinary 
tract catheterized in Urology (types 4, 9, 52 and 14), respiratory tract with respiratory 
assistance and bacteremia in Medicine (types 4, 52, 9 and 42), and abscess and post-
operative wounds in Surgery (types 4, 52 and 9). Each ward showed a speciffic bacteri-
ocin type distribution of the isolates, and these data seemed to indicate that S. marcescens 
are spread by cross infection. 
Comparison of the proportion of resistant strains between two-'hospitals: The strain with
Table 1. Distribution of the bacteriocin types of Serratia marcescen, 
         according to clinical sources
                   No. o f bacteriocin type Cli
nical source 
patients                              4 9 14 26 42 52 others 
Urine MCHO** 76 25 20 3 -* 2 13 13                 NU  39 6 1 7 8 - - 7
Sputum MCHO 17 2 3 1 3 2 6              NU  29 6 6 6 1 10
Pus & exudate MCHO 11 5 3 - - 1 1 1                NU  3 - - 1 1 - - 1 
Others MGHO 22 4 3 - - 2 8 5                 NU  15 3 3 1 - - 
    * - Not isolated 
   ** MCHO : Medical College Hospital of Oita 
     NUH . Nagasaki University Hospital
Table 2. Distribution of the bacteriocin types of Serratia marcescens 
         at each ward of Medical College Hospital of Oita during 
         Jan., 1981 to July, 1983
                Number of bacteriocin type   Ward 
patients                            4 9 14 42 52 others 
Urology 48 14 14 3 2 7 8 
Medicine 47 12 7 1 5 11 11 
Surgery 13 5 2 - * - 3 3 
Pediatrics 6 1 1 - 1 1 2 
Orthopedic Surgery 3 - 2 - - - 1 
Otorhinology 3 - 2 - - 1 -
Others 6 4 1 - - 1 -
MIC of more than 25 pg/ml was identified as the resistant one. The antimicrobial re-
sistance acquired at each hospital is shown in Fig. 2. There were no resistant strains at 
both hospitals for three antimicrobials, imipenem, astromicin and ciprofloxacin. The 
isolates from NUH were found to be generally less resistant than those from MCHO. The 
S. marcescens of bacteriocin type 9 and the strains originated from sputa at NUH were 
all sensitive to the compounds tested. Of the strains 67^-77% at MCHO and 10^-33% at
Fig. 2. Antimicrobial resistance (MIC; X25 ug/ml) of Serratia marcescens isolated from 
      Medical College Hospital of Oita (MCHO) and Nagasaki University Hospital (NUH)
Table 3. Relationship between resistance patterns (MIC: ~25pg/ml) of 
         Serratia marcescens to aminoglycosides and bacteriocin types
                          Number Bacteriocin type 
  Resistance pattern of 
                        strains 4 9 14 26 42 52 
GM-TOB-SISO-AMK* MCHO** 59 28 7 -*** - 7 17                      NU  5 3 - 2 - - -
GM-T OB-SIS O MCH O 6 - 3 1 - - 2                   NU 0 - - - - - -
TOB-SISO-AMK MCHO 6 - 4 2 - - -                    NU  3 - - 3 - - -
TOB-AMK MCHO 3 - 3 - - - -                     NU  8 1 - - 7 - -
Others MCHO 4 - 4 - - - -                    NU  1 1 - - - - -
 * GM : Gentamicin
, TOB: Tobramycin, SISO: Sisomicin, AMK : Amikacin 
** MCHO : Medical College Hospital of Oita
, NUH: Nagasaki University Hospital 
***- Not isolated
NUH were resistant against four aminoglycosides, gentamicin, tobramycin, sisomicin and 
amikacin. 
Relationship between aminoglycosides resistance patterns and bacteriocin types : Relation-
ship between aminoglycosides resistance patterns, excluding astromicin, and bacteriocin 
types of S. marcescens are shown in Table 3. Resistant strains for four antimicrobial drugs 
were most frequently isolated from MCHO, in 59 out of 101 strains (58%) ; they were 
classified into the bacteriocin types 4, followed by 52, 9 and 42 in decreasing order. Five 
strains (9%) of the isolates from NUH showed resistance for four compounds, three 
strains (which were all bacteriocin type 14) for three drugs, eight strains (of which seven 
were the bacteriocin type 26) for two agents, tobramycin and amikacin. 
                   DISCUSSION 
     S. marcescens is mostly resistant to cephalosporins and penicillins owing to chromo-
somal-mediated (3-lactamase production with mainly cephalosporinase activity. Aminoglyco-
side-resistant strains are now increasingly found among clinical isolates')'). This bacteri-
um, once used as a biological marker for pathogenicity studies, is now almost routinely 
encountered and play a role as an important opportunistic pathogen of compromised hosts 
1s)19). Following previous studies on S. marcescens infections with nosocomial distribution 
of bacteriocin types")"), comparative investigation was undertaken in two hospitals re-
motely situated from each other. 
     Epidemiologic study of infection with S. marcescens is usually carried out using 
serotyping, antibiogram, bacteriocin typing and biotyping as a marker',). Bacteriocin 
typing is also frequently utilized in tracing the nosocomial infection3)s)7)9>ll)la)l4)ls). In this 
study, the bacteriocin typing method of TRAUB, RAYMOND and STARTSMAN17), and 
the antimicrobial dilution method for antibiogram were used in order to compare S. 
marcescens distribution at both hospitals owing to their simple methodology. The results 
obtained from two university hospitals demonstrated characteristic distribution of bacteri-
ocin types and antibiograms at each hospital, suggesting the different ecology in in-
patients or hospital environments at the MCHO and NUH respectively. Bacteriocin types 
4 and 9 constituted a high proportion of S. marcescens isolates at both hospitals, similar 
findings were reported by TRAUB and RAYMOND15), indicating that these types are 
most common among clinical isolates. From 1976 to 1978 bacteriocin type 26 was most 
predominant at NUH, constituting 41% of isolates, followed by types 4 and 912). In the 
present study at the same hospital, however, types 14, 4 and 9 were the most common 
and the type 26 was only 12%. This apparently showed that as the hospital population 
changes a concomitant change in the nosocomial bacteria also occurs, suggesting the need 
for follow-up studies at intervals of some years. Of the strains isolated 12^•16% were 
nontypable by bacteriocin typing method used in this study. However this method was 
considered to be useful in studies of nosocomial infection with S. marcescens, because of 
good reproducibility o f results.
     Antibiogram may be easily utilized as epidemiologic tool at the hospital laboratory 
level, but it changes in antimicrobial susceptibility related to environmental factors or 
R-plasmid. The strains isolated from NUH were found to be less resistant than those 
from MCHO. The antimicrobial resistance patterns of S. marcescens for aminoglycosides 
were different in distribution at each hospital. These facts may suggest that the resistant 
strains are selected by using antimicrobial agents and they are spread in each hospital. 
The close correlation between bacteriocin types and antimicrobial resistance patterns was 
not evident because of the phenotypic variation and transferable R-plasmid of the bac-
teria. It seems reasonable to conclude that bacteriocin typing and antibiogram are useful 
and effective for the surveillence and control of nosocomial infection with S. marcescens 
i f they are used at the same time. 
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